Author

Walter J. Storkus

University of PittsburghORCID 0000-0001-8961-4444Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Abrahim Kashkoush· 1 shared Akata SahaiD· 1 shared Anamika BoseiD· 1 shared Anirban SarkariD· 1 shared Avishek BhuniyaiD· 1 shared Ayushi VermaiD· 1 shared Debarati BhariD· 1 shared Dipak B. DattaiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abrahim Kashkoush

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyThe Journal of ImmunologyPeer-reviewedOct 1, 2026

Experimental type 1 diabetes metabolically rejuvenates CD8+ T cells for improved control of tumor growth through an IGF1-IGF1R axis

Anirban Sarkar, Sukanya Dhar, Saurav Bera…·Anamika Bose

This study shows that experimental type 1 diabetes enhances CD8+ T cell function via the IGF1-IGF1R axis, leading to better tumor control.

DOI 10.1093/jimmun/vkag262

mouseproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 10, 2026

Profilin-1 Deficiency Activates STING to Drive T Cell-Mediated Anti-Tumor Immunity in Breast Cancer

Ian Eder, Masoumeh Baghaei, Sudeep K. Maurya…·Partha Sarathi Roy

This paper shows that reducing Profilin-1 in breast cancer cells triggers genomic instability and activates the cGAS-STING pathway, enhancing T cell-mediated anti-tumor immunity and leading to tumor regression.

DOI 10.64898/2026.06.05.730362

mousegenetic perturbation / CRISPR

𝕏 PostBluesky